resulted in reproducibly higher recanalization rates3'-2 (table 1) . The -influence of intracoronary infusion of streptokinase on ejection fractiom has been assessed in five controlled trials3, 4. 7, 8. 12 (table 2) , but only Anderson et al. 4 found a significant improvement in left ventricular function from the acute to the chronic stage of infarction in patients treated with streptokinase. Lack of functional improvement in the majority of trials has been attributed to a delay of more than 4 hr between onset of infarction and commencement of therapy. However, Leiboff et data suggest that the value of recanalization in salvaging myocardium decreases rapidly with time. 1 Second, preintervention angiographic studies revealed incomplete obstruction of the infarct-related vessel in 5% to 33% of the patients (table 5) ; these patients were excluded from the analysis of recanalization rates. Such a differentiation is not possible without the use of preintervention angiographic evaluation. Early peaking of creatine kinase levels does not reliably identify streptokinase-induced recanalization, since creatine kinase levels also peak early in patients with incomplete coronary obstruction at baseline angiographic examination.'2 Therefore, in the absence of preintervention angiograms, recanalization rates are likely to be overestimated. Complications associated with intravenous infusion of streptokinase are primarily related to bleeding. The reported incidence of bleeding with highdose, short-term intravenous infusion of streptokinase varies between 0% and 2 1 %.20, 21, 23. 25, 26, 28 This variation may be related to relatively small sample size in the studies, lack of a standard definition of complica- 
